These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24839818)

  • 1. Detection of circulating methylated opioid binding protein/cell adhesion molecule-like gene as a biomarker for ovarian carcinoma.
    Zhou F; Ma M; Tao G; Chen X; Xie W; Wang Y; Cao X
    Clin Lab; 2014; 60(5):759-65. PubMed ID: 24839818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.
    Czekierdowski A; Czekierdowska S; Szymanski M; Wielgos M; Kaminski P; Kotarski J
    Neuro Endocrinol Lett; 2006 Oct; 27(5):609-13. PubMed ID: 17159813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
    Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
    Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.
    Zhou F; Cao X; Liu M; Wang Y; Tao G
    Clin Lab; 2011; 57(5-6):421-4. PubMed ID: 21755835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of circulating hypermethylated tumor-specific RASSF1A DNA in ovarian cancer patients].
    Ma L; Liu FR; Zhang SL
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):785-7. PubMed ID: 16545186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma.
    Chen H; Ye F; Zhang J; Lu W; Cheng Q; Xie X
    Eur J Gynaecol Oncol; 2007; 28(6):464-7. PubMed ID: 18179137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma].
    Zhang J; Ye F; Chen HZ; Ye DF; Lu WG; Xie X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):173-7. PubMed ID: 16733898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of multiplex nested methylated specific PCR in early diagnosis of epithelial ovarian cancer.
    Wang B; Yu L; Yang GZ; Luo X; Huang L
    Asian Pac J Cancer Prev; 2015; 16(7):3003-7. PubMed ID: 25854397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
    Mei FC; Young TW; Liu J; Cheng X
    FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
    Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer.
    Xing BL; Li T; Tang ZH; Jiao L; Ge SM; Qiang X; OuYang J
    Genet Mol Res; 2015 May; 14(2):4532-40. PubMed ID: 25966226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.
    Amornpisutt R; Proungvitaya S; Jearanaikoon P; Limpaiboon T
    Tumour Biol; 2015 Jul; 36(7):4973-8. PubMed ID: 25652468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
    Lian B; Li H; Liu Y; Chai D; Gao Y; Zhang Y; Zhou J; Li J
    Breast Cancer; 2021 Mar; 28(2):448-458. PubMed ID: 33108608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors].
    Ma L; Zhang JH; Liu FR; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):657-9. PubMed ID: 16438885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
    Terp SK; Stoico MP; Dybkær K; Pedersen IS
    Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer.
    Wang B; Yu L; Luo X; Huang L; Li QS; Shao XS; Liu Y; Fan Y; Yang GZ
    Oncol Lett; 2017 Jul; 14(1):217-223. PubMed ID: 28693156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer.
    Zhang N; Xu J; Wang Y; Heng X; Yang L; Xing X
    Oncol Lett; 2018 Jun; 15(6):9973-9977. PubMed ID: 29805691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.
    Cui Y; Ying Y; van Hasselt A; Ng KM; Yu J; Zhang Q; Jin J; Liu D; Rhim JS; Rha SY; Loyo M; Chan AT; Srivastava G; Tsao GS; Sellar GC; Sung JJ; Sidransky D; Tao Q
    PLoS One; 2008 Aug; 3(8):e2990. PubMed ID: 18714356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.
    McKie AB; Vaughan S; Zanini E; Okon IS; Louis L; de Sousa C; Greene MI; Wang Q; Agarwal R; Shaposhnikov D; Wong JL; Gungor H; Janczar S; El-Bahrawy M; Lam EW; Chayen NE; Gabra H
    Cancer Discov; 2012 Feb; 2(2):156-71. PubMed ID: 22585860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.